Johnson & Johnson completes first cases with OTTAVA robotic surgical system

While J&J has actually maintained its Ottava robotic under covers, it stated the system uses medical groups the capacity to adjust to professional operations and private client demands.|Resource: Johnson & Johnson

Johnson & Johnson MedTech today introduced that it has actually finished the initial instances in the professional test for its OTTAVA Robotic Surgical System. The instances note the initial professional experience with the OTTAVA System, it stated.

” We are pleased to reach this essential landmark in our robot surgical procedure program,” stated Hani Abouhalka, the firm team chairman of surgical procedure at Johnson & Johnson MedTech.

” OTTAVA is a crucial technology in our profile of sophisticated medical innovations– every one of which are created to change the medical experiences throughout all surgical procedure,” he included. “Our individuals function side-by-side with medical groups in ORs [operating rooms] around the globe daily to increase the requirement of take care of clients and supply what’s following in surgical procedure.”

Johnson & Johnson MedTech is a Warsaw, Ind.-based device of Johnson & Johnson (J&J), which has greater than 100 years of experience in medication and medical modern technology. The firm stated its profile consists of robotics, injury closure, adjunctive hemostats, medical stapling and tools, and electronic systems.

OTTAVA addresses medical robotics drawbacks

The United State Fda (FDA) approved OTTAVA an investigational gadget exception in late 2024. Johnson & Johnson MedTech stated it created the system to breakthrough professional technology as a whole surgical procedure, a considerable component of its wider surgical procedure company.

J&J explained OTTAVA as “a multi-specialty soft-tissue surgical procedure robotic, sustaining a wide variety of treatments throughout individual composition and medical specializeds, consisting of one of the most complicated surgical procedures that call for a multi-quadrant strategy.” The system’s merged design, medical instrumentation improved J&J’s Ethicon experience, and a prepared link to the Polyphonic electronic ecological community are meant to satisfy the demands of each individual’s treatment and each cosmetic surgeon’s professional strategy, the firm insisted.

Johnson & Johnson MedTech initially shared information concerning OTTAVA concerning 4 years back. Ever since, it has actually been reasonably silent. In October 2021, the firm pressed back the system’s advancement timeline by concerning 2 years, mentioning numerous elements.

OTTAVA’s first layout consisted of 6 robot arms. In November 2023, a J&J upgrade consisted of modifications, consisting of 4 arms to be offered as needed.

Register currently so you do not lose out!

Johnson & Johnson MedTech preparations for following actions

Dr. Erik Wilson is the principal of minimally intrusive and optional basic surgical procedure at the College of Texas Wellness Houston and the lead detective for the professional research. He executed a Roux-en-Y gastric-bypass surgical procedure utilizing the OTTAVA Robotic Surgical System at Memorial Hermann-Texas Medical Facility.

” Surgical robotics goes to the leading edge of technology in minimally intrusive surgical procedure,” stated Wilson. “I am pleased to have actually executed the initial professional research instances with OTTAVA and possibly aid progress the requirement in medical robotics.”

Johnson & Johnson MedTech prepares to utilize information from this test intends to sustain the medical system’s capacity to do a range of treatments. Upon conclusion of the research, the firm prepares to send the OTTAVA system for Afresh permission in the united state

J&J stated it will certainly target a sign covering numerous treatments as a whole surgical procedure within the top abdominal area. These consist of stomach bypass, stomach sleeve, tiny digestive tract resection, and hiatal rupture repair work.

” As a firm running at the junction of biology and modern technology, professional proof generation is the core of our technology programs to progress medical modern technology for clients,” stated Peter Schulam M.D., Ph.D., and primary clinical policeman at Johnson & Johnson MedTech. “With this professional research, we are pleased to be partnering with doctors to collect proof and sustain the recurring search of clinical research for the improvement of robotic-assisted minimally intrusive surgical procedure.”

The OTTAVA robot system is under advancement and is not yet licensed to be marketed or marketed in any kind of market, kept in mind J&J.

The message Johnson & Johnson finishes initial instances with OTTAVA robot medical system showed up initially on The Robotic Record.